Cargando…
Identification and Inhibition of the Druggable Allosteric Site of SARS-CoV-2 NSP10/NSP16 Methyltransferase through Computational Approaches
Since its emergence in early 2019, the respiratory infectious virus, SARS-CoV-2, has ravaged the health of millions of people globally and has affected almost every sphere of life. Many efforts are being made to combat the COVID-19 pandemic’s emerging and recurrent waves caused by its evolving and m...
Autores principales: | Faisal, Shah, Badshah, Syed Lal, Kubra, Bibi, Sharaf, Mohamed, Emwas, Abdul-Hamid, Jaremko, Mariusz, Abdalla, Mohnad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416396/ https://www.ncbi.nlm.nih.gov/pubmed/36014480 http://dx.doi.org/10.3390/molecules27165241 |
Ejemplares similares
-
Computational Study of SARS-CoV-2 RNA Dependent RNA Polymerase Allosteric Site Inhibition
por: Faisal, Shah, et al.
Publicado: (2021) -
Alkaloids as potential antivirals. A comprehensive review
por: Faisal, Shah, et al.
Publicado: (2023) -
Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase
por: Benoni, Roberto, et al.
Publicado: (2021) -
Identification of novel mutations in the methyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2
por: Azad, Gajendra Kumar
Publicado: (2020) -
Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening
por: Bobrovs, Raitis, et al.
Publicado: (2021)